Crinetics Pharmaceuticals (CRNX) Cash from Financing Activities (2017 - 2026)
Crinetics Pharmaceuticals' Cash from Financing Activities came in at $8.93 million for Q2 2026, up 26.5% from $7.06 million a year earlier but down 97.7% from the prior quarter.
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Crinetics Pharmaceuticals reported Cash from Financing Activities of $427.92 million, down 31.5% year-over-year; for FY2025, it was $40.61 million, down 96.0% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of -18.7% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $1.01 billion in FY2024 (+159.3%), $391.24 million in FY2023 (+220.8%), $121.96 million in FY2022 (-51.7%) and $252.68 million in FY2021 (+120.5%).
- The five-year range for quarterly Cash from Financing Activities is $115,000 (Q4 2022) to $556.24 million (Q4 2024).
- Year-over-year, Cash from Financing Activities increased in 1 of the last six quarters, with an average decline of 58.6%.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q2 2022 (growth of 62.3%), and the weakest in Q4 2022 (a decline of 99.9%).
- Business Quant data shows CRNX's Cash from Financing Activities at $389.88 million (Q1 2026), $26.04 million (Q4 2025) and $3.08 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | 8.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.93 Mn |
| Mar 31, 2026 | 389.88 Mn |
| Dec 31, 2025 | 26.04 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 4.44 Mn |
| Dec 31, 2024 | 556.24 Mn |
| Sep 30, 2024 | 57.33 Mn |
| Jun 30, 2024 | 7.52 Mn |
| Mar 31, 2024 | 393.57 Mn |
| Dec 31, 2023 | 40.22 Mn |
| Sep 30, 2023 | 337.88 Mn |
| Jun 30, 2023 | 12.66 Mn |
| Mar 31, 2023 | 484,000.00 |
| Dec 31, 2022 | 115,000.00 |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 118.99 Mn |
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 163.86 Mn |
| Sep 30, 2021 | 15.46 Mn |
API Access
Crinetics Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CRNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();